• 1. Aggregation behaviour of biocompatible choline carboxylate ionic liquids and their interactions with biomolecules through experimental and theoretical investigations?
  Somenath Panda,Kaushik Kundu,Anusha Basaiahgari,Sanjib Senapati,Ramesh L. Gardas New J. Chem., 2018,42, 7105-7118
• 2. An apparatus for determining small amounts of alchohol in sour milk and urine
  Analyst, 1964,89, 272-275
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 5. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864

Introduction to 4,4-Diphenylpiperidine Hydrochloride (CAS No. 63675-71-8)

4,4-Diphenylpiperidine Hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 63675-71-8, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This compound belongs to the piperidine class of heterocyclic amines, characterized by a six-membered ring containing one nitrogen atom. The presence of two phenyl groups at the 4-position of the piperidine ring imparts unique chemical and pharmacological properties, making it a subject of considerable interest in drug discovery and development.

The hydrochloride salt form of 4,4-Diphenylpiperidine Hydrochloride enhances its solubility in aqueous solutions, which is a critical factor for formulation in pharmaceutical applications. This solubility profile facilitates its use in various drug delivery systems, including oral and parenteral formulations. The compound's molecular structure, featuring a piperidine core with phenyl substituents, suggests potential interactions with biological targets such as receptors and enzymes, which are pivotal in modulating physiological processes.

In recent years, the pharmaceutical industry has witnessed a surge in the exploration of piperidine derivatives due to their diverse biological activities. 4,4-Diphenylpiperidine Hydrochloride has been extensively studied for its potential role in the development of central nervous system (CNS) therapeutics. Its structural motif is reminiscent of several established drugs that target neurotransmitter systems, particularly those involving dopamine and serotonin. This has spurred research into its possible applications as an intermediate in synthesizing novel psychoactive agents or as a lead compound for further structural optimization.

One of the most compelling aspects of 4,4-Diphenylpiperidine Hydrochloride is its versatility in serving as a scaffold for medicinal chemistry investigations. Researchers have leveraged its framework to develop compounds with enhanced pharmacokinetic profiles or improved binding affinity to specific therapeutic targets. For instance, modifications to the phenyl rings or the piperidine nitrogen can be engineered to fine-tune metabolic stability, bioavailability, and selectivity. Such structural manipulations are essential for creating drug candidates that meet stringent pharmacological requirements.

The synthesis of 4,4-Diphenylpiperidine Hydrochloride typically involves multi-step organic reactions, starting from readily available precursors such as benzene derivatives and piperidine. Advanced synthetic methodologies, including transition metal-catalyzed cross-coupling reactions and asymmetric synthesis techniques, have been employed to achieve high yields and enantiopurity where necessary. These synthetic routes not only highlight the compound's synthetic accessibility but also underscore the advancements in synthetic organic chemistry that enable the production of complex molecules like 4,4-Diphenylpiperidine Hydrochloride.

From a pharmacological perspective, 4,4-Diphenylpiperidine Hydrochloride has demonstrated intriguing interactions with various biological receptors. Studies have indicated its potential as a ligand for sigma receptors, which are implicated in conditions ranging from neurodegenerative disorders to pain management. Additionally, its structural similarity to known antipsychotic and antidepressant agents has prompted investigations into its efficacy in modulating CNS function. Preclinical studies have explored its effects on neurotransmitter release and receptor occupancy, providing valuable insights into its pharmacological mechanism of action.

The exploration of 4,4-Diphenylpiperidine Hydrochloride extends beyond traditional CNS applications. Emerging research suggests that this compound may exhibit properties relevant to other therapeutic areas, such as anti-inflammatory or analgesic effects. By modulating inflammatory pathways or pain signaling mechanisms, 4,4-Diphenylpiperidine Hydrochloride could serve as a novel therapeutic entity for conditions characterized by chronic inflammation or neuropathic pain. Such findings underscore the compound's broad pharmacological potential and highlight its significance as a research tool.

In conclusion,4,4-Diphenylpiperidine Hydrochloride (CAS No. 63675-71-8) represents a fascinating subject of study in pharmaceutical chemistry. Its unique structural features and demonstrated biological activities position it as a valuable asset in drug discovery efforts aimed at addressing neurological and other therapeutic challenges. As research continues to uncover new applications and refine synthetic methodologies,4,4-Diphenylpiperidine Hydrochloride is poised to play an increasingly pivotal role in the development of next-generation pharmaceuticals.

• 3329-14-4(Fenpiprane hydrochloride)
• 10272-50-1(Piperidine,1-methyl-4-phenyl-, hydrochloride (1:1))
• 13657-24-4(1H-Azepine,1-(3,3-diphenylpropyl)hexahydro-, hydrochloride (1:1))
• 34273-01-3(Piperidine,4,4-diphenyl-)
• 3540-95-2(Fenpiprane)
• 31329-36-9(Piperidine,1-methyl-4,4-diphenyl-, hydrochloride (1:1))
• 37088-47-4(Piperidine,1-(3,3-diphenylpropyl)-4-phenyl-, hydrochloride (1:1))
• 31309-39-4(Piperidine,1-methyl-4,4-diphenyl-)
• 15037-51-1(Piperidine,4-phenyl-1-propyl-, hydrochloride (1:1))
• 5426-23-3(Benzenebutanamine,N,N-diethyl-d-phenyl-,hydrochloride (1:1))